![Logo for OptiNose Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F96853-2023-03-07-08-25-23.png&w=256&q=100)
OptiNose Investor Relations Material
Latest events
![Logo for OptiNose Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F96853-2023-03-07-08-25-23.png&w=128&q=100)
Q1 2024
OptiNose
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from OptiNose Inc
Access all reports
OptiNose Inc. is a pharmaceutical company engaged in the development and commercialization of innovative products for patients under the care of ear, nose, throat, and allergy specialists in the United States. The company has developed a proprietary Exhalation Delivery Systems, a novel drug delivery concept that facilitates broad, consistent drug delivery deep within the nasal passages. This technology aims to leverage the mucosal surfaces as a potential target for treating both local and systemic diseases. OptiNose's portfolio includes XHANCE, a therapeutic product utilizing EDS to deliver a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. Additionally, the company has developed Onzetra Xsail, a powder EDS device, and is exploring further applications of its technology in various clinical trials. OptiNose is headquartered in Yardley, Pennsylvania, and its shares are listed on the NASDAQ.
Key slides for OptiNose Inc
![Forward - Looking St](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Foptinose-inc-q1-2024-1f0c490c2e186661%2F2.png&w=3840&q=75)
![Logo for OptiNose Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F96853-2023-03-07-08-25-23.png&w=128&q=100)
Q1 2024
OptiNose Inc
![Forward - Looking St](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Foptinose-inc-q4-2023-da7cae8c0167bb1b%2F2.png&w=3840&q=75)
![Logo for OptiNose Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F96853-2023-03-07-08-25-23.png&w=128&q=100)
Q4 2023
OptiNose Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
OPTN
Country
🇺🇸 United States